Uncategorized-EN
New Horizons GIST 2020 – GOES virtual
The corona virus has dramatically changed our private lives and our lives as Patient Advocates worldwide. So, also NEW HORIZONS GIST 2020 was held virtually! As many of you have already experienced: NEW HORIZONS GIST is a great opportunity where “GIST Patient Advocates / GIST Patient Group Leaders” from around the world are…
Read MoreResearch Priorities in Bone Sarcomas
Bone sarcomas are a diverse and hard to treat group of rare cancers. People with bone sarcomas (or primary bone cancer) have high unmet medical needs, and face a range of challenges including delays to diagnosis, disparities in access to treatments and a relative lack of clinical trial and research opportunities. Take part in the first…
Read MoreThe SPAEN Sarcoma Research Group
Research in sarcomas needs to become more patient-centric! {loadmoduleid 124} We feel that research decision making sometimes depend on other reasons than actual needs and most important questions for patients. Therefore, we would like to work towards developing a strategy and clear direction to ultimately improve outcomes for sarcoma patients – in a collaborative effort…
Read MoreSPAEN supports cancer/sarcoma patients from Ukraine with a donation of 10.000 Euro
Wölfersheim/Germany, March 15, 2022 The current situation in Ukraine is a humanitarian catastrophe and we strongly condemn this unjustified war of aggression against Ukraine by Russian’s president Wladimir Putin. As a global organization, Sarcoma Patients EuroNet Assoc. (SPAEN) stands in solidarity with all Ukrainians. However, this situation of war is even worse for cancer…
Read MoreQuality of Life and the Patient Perspective in Research
{loadposition position-18} Why should the patient perspective be assessed in cancer and sarcoma treatment? And how can measuring patient-reported outcomes improve the situation for patients? What additional information can patient-reported outcomes provide in the setting of clinical trials? Dr. Olga Husson, epidemiologist from the Netherlands Cancer Institute explains why assessing QoL is so important and…
Read MoreMember activities
Our member organisations are very active in their countries – we are very proud to present a selection of what is happening for sarcoma and GIST patients in the world. We thank all our organisation for their outstanding commitment! July 2019 Friends of Max Newsletter with special focus on GIST Our – Sarcoma Patients EuroNet’s…
Read MoreStatistics – Traffic and Visitors
{loadposition traffic}
Read MoreSPAEN Advocacy Campus
Soon to come more…
Read MoreOur Webinars at the SPAEN Advocacy Campus
There are a lot of open questions about sarcomas by patients and patient advocates or even healthcare professionals, but not everybody can attend a congress or a conference to seek answers. SPAEN therefore launched the series of webinars on the SPAEN Advocacy Campus: To tackle important issues and answer relevant questions, we invite renowned experts…
Read MoreWebinars (2)
SPAEN is happy to announce that our first webinars are on the way for late summer 2018! The role of radiotherapy in sarcomas & recent developmentsRick Haas, MD, PhD, Radiation-oncologist, The Netherlands Cancer Institute, The NetherlandsSeptember 19, 2018, 6 pm CET Experiences with olaratumab in soft tissue sarcomaDr. Robin Jones, Medical Oncologist, Head of…
Read More